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Abstract
The Wnt receptor Ryk is an evolutionary-conserved protein important during neuronal differentiation through several
mechanisms, including c-secretase cleavage and nuclear translocation of its intracellular domain (Ryk-ICD). Although the
Wnt pathway may be neuroprotective, the role of Ryk in neurodegenerative disease remains unknown. We found that Ryk is
up-regulated in neurons expressing mutant huntingtin (HTT) in several models of Huntington’s disease (HD). Further
investigation in Caenorhabditis elegans and mouse striatal cell models of HD provided a model in which the early-stage
increase of Ryk promotes neuronal dysfunction by repressing the neuroprotective activity of the longevity-promoting factor
FOXO through a noncanonical mechanism that implicates the Ryk-ICD fragment and its binding to the FOXO co-factor b-
catenin. The Ryk-ICD fragment suppressed neuroprotection by lin-18/Ryk loss-of-function in expanded-polyQ nematodes,
repressed FOXO transcriptional activity, and abolished b-catenin protection of mutant htt striatal cells against cell death
vulnerability. Additionally, Ryk-ICD was increased in the nucleus of mutant htt cells, and reducing c-secretase PS1 levels
compensated for the cytotoxicity of full-length Ryk in these cells. These findings reveal that the Ryk-ICD pathway may impair
FOXO protective activity in mutant polyglutamine neurons, suggesting that neurons are unable to efficiently maintain
function and resist disease from the earliest phases of the pathogenic process in HD.
Citation: Tourette C, Farina F, Vazquez-Manrique RP, Orfila A-M, Voisin J, et al. (2014) The Wnt Receptor Ryk Reduces Neuronal and Cell Survival Capacity by
Repressing FOXO Activity During the Early Phases of Mutant Huntingtin Pathogenicity. PLoS Biol 12(6): e1001895. doi:10.1371/journal.pbio.1001895
Academic Editor: Hugo J. Bellen, Baylor College of Medicine, United States of America
Received October 21, 2013; Accepted May 15, 2014; Published June 24, 2014
Copyright:  2014 Tourette et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Inserm and Associated International Laboratory ‘Neuronal longevity’ (http://www.inserm.fr/), AP-HP (http://www.aphp.fr/),
‘‘Equipe FRM Ile-de-France’’ program of the Fondation pour la Recherche Me´dicale (http://www.frm.org/) Grant DEQ20061107955, the Agence Nationale de la
Recherche (http://www.agence-nationale-recherche.fr/) Grants ANR-08-MNPS-024-01 and ANR-12-BSV4-0023-01 and the Association Franc¸aise contre les
Myopathies (http://www.afm-telethon.fr/), Paris, France, and the Hereditary Disease Foundation (http://www.hdfoundation.org/home.php) and CHDI Foundation
(http://chdifoundation.org/), USA. C.T. is supported by AP-HP under the University Hospital Department ‘Fight Aging and Stress’ program. J.A.P. was supported by
a Young Researcher Award from Inserm. R.V. was supported by a Poste Vert fellowship from Inserm. J.V. is supported by the Association Huntington France. J.K. is
supported by the Bumpus Foundation. This work was also supported by National Institutes of Health (http://www.nih.gov/) Grants NS045242, NS045806,
NS058793, and NS066912, and by the Veterans Administration (http://www.va.gov/) (R.J.F.). The Cell Imaging and Flow Cytometry facility of the IFR 83 (Paris,
France) is supported by the Conseil regional Ile-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist. Dr. Robert Ferrante is listed as an author of our paper, but at the time of
acceptance was not reachable or able to confirm details of his author contributions to the manuscript. The corresponding author, Christian Neri, has therefore
supplied the information regarding his contribution to the manuscript and his competing interests and it is correct to the best of Christian Neri’s knowledge.
* Email: christian.neri@inserm.fr
¤a Current address: Sensorineural Disorders, Health Research Institute-La Fe, Valencia, Spain.
¤b Current address: Department of Neuroscience, University of Montreal, Centre de Recherche du Centre Hospitalier de l’Universite´ de Montreal (CRCHUM),
Montreal, Quebec, Canada.
Abbreviations: AD, Alzheimer’s disease; APP, amyloid precursor protein; CTF, C-terminal fragment; DAPI, diamidino-2-phenylindole; ECL, enhanced
chemiluminescence; FACS, Fluorescence Activated Cell Sorting; FHRE, Forkhead responsive element; GSEA, Gene Set Enrichment Analysis; HD, Huntington’s
disease; HTT, huntingtin; ICD, intracellular domain; LOF, loss-of-function; NOS, nitric oxide synthase; polyQ, polyglutamines.
PLOS Biology | www.plosbiology.org 1 June 2014 | Volume 12 | Issue 6 | e1001895
Introduction
Cell stress response factors are important for cells to maintain
function in a large variety of normal and pathological contexts,
including diseases linked to proteotoxicity [1]. Among these
factors, the FOXO family of Forkhead transcription factors is
central to longevity and cellular homeostasis [2,3]. Additionally,
FOXO factors may be important to the regulation of neuron
survival in neurodegenerative diseases such as Huntington’s
disease (HD) [4,5], a dominantly inherited CAG repeat disorder
caused by expanded polyglutamines (polyQ) in the N-terminal
portion of huntingtin (HTT) and characterized by striatal and
cortical degeneration [6]. FOXO may indeed promote neuron
survival in simple models of HD [7] and cellular proteostasis in
simple models of Alzheimer’s disease (AD) [8]. Interestingly, the
canonical Wnt pathway component b-catenin may functionally
interact with FOXO in oxidative stress signaling [9] and has a
neuroprotective role in models of the early phases of the
pathogenic process in HD [10]. This suggests that the canonical
Wnt pathway may interact with the FOXO pathway to promote
diseased-neuron function and survival, which is in line with the
notion that neuronal differentiation factors such as Wnts may
promote adult neuron survival [11]. However, Wnt signaling
effectors may be impaired in HD and AD [12–14], raising the
possibility that Wnt pathways may have a dual role in the
regulation of neurodegeneration. Here, we hypothesized that
alteration of Wnt pathways might antagonize the FOXO pathway
to compromise cell stress response and neuronal resistance during
the earliest phases of the pathogenic process in neurodegenerative
disease such as HD. To test for this hypothesis, we used
Caenorhabditis elegans transgenics that recapitulate an early phase
of mutant HTT toxicity, namely neuronal dysfunction before cell
death [15]. At the young adult stage, these animals show a
dramatic loss of response to light touch produced by polyQ-
expanded exon-1 like HTT fused to GFP in touch receptor
neurons [15]. To assess the mechanisms that underlie the
dysfunction of these neurons, we performed a microarray analysis
of primary neurons upon Fluorescence Activated Cell Sorting
(FACS) of embryonic cells. This analysis emphasized the
deregulation of neuronal differentiation genes, notably genes that
are up-regulated in expanded-polyQ nematodes and in the brain
of HD patients such as Ryk. Ryk is an evolutionary-conserved Wnt
receptor (lin-18 in C. elegans) that is important to neurogenesis and
axon guidance [16–18] and that is involved in the regulation of
developmental/postdevelopmental processes such as planar cell
polarity [19,20], regeneration [21], and hematopoietic repopula-
tion [22]. Further investigation revealed that loss-of-function
(LOF) of lin-18/Ryk in polyQ nematodes and reduction of Ryk
levels in mouse striatal cells derived from HdhQ111 knock-in mice
[23] strongly protected from expanded polyQ/mutant HTT.
Neuroprotection by lin-18 LOF in expanded-polyQ nematodes, a
cell-autonomous process, required the neuroprotective factor daf-
16/FOXO [7], suggesting that lin-18 represses the neuroprotective
activity of daf-16 in these animals. The intracellular domain of Ryk
(Ryk-ICD), a c-secretase cleavage product that translocates in the
nucleus to control neurogenesis [16,17], was found to bind to the
FOXO partner b-catenin, suggesting that Ryk-ICD may trigger
the repression of FOXO by increased levels of Ryk in mutant
polyQ neurons. In support of this mechanism, Ryk-ICD
overexpression was sufficient to repress the transcriptional activity
of FOXO3a, a protein that promotes the survival of mutant htt
striatal cells. Additionally, LIN-18 ICD expression was sufficient to
suppress neuroprotection by lin-18 LOF in expanded-polyQ
nematodes. This mechanism was further supported by results in
mutant htt cells showing that (i) Ryk-ICD overexpression
abolished the protective activity of b-catenin, which is consistent
with the possibility that an excess of Ryk-ICD may bind and block
this survival protein; (ii) reducing presenilin PS1 levels (which is
protective) compensated for the cytotoxicity of full-length Ryk but
not that of Ryk-ICD, implicating this c-secretase in the toxic
effects of Ryk; and (iii) nuclear levels of endogenous Ryk-ICD were
increased compared to normal htt cells, corroborating a role for
the Ryk-ICD pathway in triggering abnormal Ryk signaling in
mutant htt cells. Finally, Ryk was suggested to have a pathological
role in HD as emphasized by the early stage (before or during the
onset of pathology) increase of Ryk in expanded-polyQ nematodes
[7] and the neostriatum of 140CAG knock-in mice [24].
Collectively, these results suggest that Ryk and its ICD fragment
may reduce the ability of mutant polyQ neurons to handle cell
stress and maintain function by repressing FOXO protective
activity, which may occur during the earliest phases of the
pathogenic process in HD.
Results
Microarray Data Analysis Highlights Axon Guidance
Pathways
To explore the pathways that underlie the early phases of
expanded-polyQ neurotoxicity, we performed a microarray
analysis of mRNAs extracted from C. elegans touch receptor cells.
To this end, we used transgenic nematodes expressing polyQ-
expanded (128Q) and normal (19Q) N-terminal HTT fused to
GFP under the control of the mec-3 promoter [15], and transgenic
nematodes expressing only GFP under the control of the same
Author Summary
Neuronal cell decline in neurodegenerative disease can be
caused by inherited mutations and involves neuronal
dysfunction followed by neuronal death. The ability of
neurons to cope with the chronic stress induced by
mutant protein expression may determine the course of
their decline and eventual demise. Although the patho-
physiological importance of these stress responses has
been previously shown, very little is known about the
signaling networks that regulate neuronal homeostasis
during the early presymptomatic—but pathogenic—phas-
es of a neurodegenerative disorder such as Huntington’s
disease (HD). In particular, it remains unclear whether
neuronal differentiation factors regulate stress response
pathways during neurodegenerative disease and how this
might impact the overall capacity of neurons to cope with
stress and maintain their function. Here, we show that the
Wnt receptor Ryk, a protein known to be important for
neurogenesis, is increased in different animal models of
HD, before or during the early phases of the disease
process. Interestingly, increased levels of Ryk repress
activity of the FOXO proteins—a family of transcription
factors that play a role in cell survival/longevity and in
neuronal homeostasis and protection. Ryk represses FOXO
protective activity, possibly directly, through its intracellu-
lar domain, a product of c-secretase–mediated cleavage
previously implicated in the birth of new cortical neurons.
This highlights the regulation of HD neuron survival by a
Ryk-dependent pathway that is distinct from canonical
Wnt/Ryk signaling. From our findings, we postulate that
neurons are unable to develop an efficient FOXO-mediat-
ed survival response during the very early, pathogenic
phases of HD.
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promoter as a control. In this model, expanded polyQ expression
produces a strong level of neuronal dysfunction not found in
normal polyQ animals, namely the loss of response to light touch
[15]. GFP-positive cells were purified by cell sorting from primary
cultures of embryonic cells prior to mRNA extraction and
microarray analysis. Forty-one genes were deregulated in 19Q
cells compared to cells expressing GFP only (Table S1). A total of
2,070 genes were deregulated in 128Q cells compared to 19Q cells
(Table S2). Interestingly, only 18 of the 2,070 genes were also
deregulated in 19Q nematode cells, suggesting that our microarray
analysis has provided clean and specific information on the
transcriptomic effects of expanded-polyQ expression. To analyze
the biological content of these data, we used several methods
including Gene Ontology analysis, Gene Set Enrichment Analysis
(GSEA), and a powerful network-based method based on Fourier
analysis (see Text S2). In contrast to the GO analysis (Figure S1),
the GSEA and Fourier analyses highlighted several processes
previously suspected to be altered in HD (see Text S1, Figure S2,
Figure S3, and Tables S3–S5), suggesting that nematode data are
relevant to HD pathogenesis. Additionally, cell differentiation
pathways such as Wnt signaling were emphasized as components
potentially involved in expanded-polyQ neuron dysfunction, a
trend also emphasized by the network-based analysis of data
resulting from a large-scale functional RNAi screen in our
expanded-polyQ nematodes [25].
Among the up-regulated Fourier modules, module 40 (Wnt/
TGF-b signaling) was of particular interest (Figure S4). This
module suggested that lin-18/Ryk, a Wnt receptor important
during neurogenesis and axon guidance [26,27], is up-regulated in
neurons expressing expanded polyQs, which was confirmed by
qRT-PCR (Table S5). To enhance the prioritization of candidate
genes, we focused on pathways and processes that were highlighted
by GSEA and by the Fourier analysis and that contained
evolutionary conserved druggable [28] genes (Table S6). Up-
regulated module 40 was again pointed out, as it contained the
largest number of genes in common with the GSEA and Fourier
analyses (see Wnt, cell cycle, and TGF-b in Table S4) as well as 3 of
the 25 genes deregulated in 128Q nematode cells and in the caudate
nucleus of HD patients [29], among which was lin-18/Ryk.
LOF of lin-18/Ryk Protects Nematode Neurons from
Expanded PolyQs
In the up-regulated Fourier module 40 (Figure S4), the
conserved lin-18 gene was of interest in the Wnt pathway as a
druggable gene that may be deregulated in the touch receptor cells
of expanded-polyQ nematodes and caudate nucleus of HD
patients. Although target gene activation is an option for
developing disease-modifying strategies, target inhibition is usually
regarded as a more easily achievable approach. Interestingly in
this respect, neuronal dysfunction was abolished by lin-18/Ryk
LOF in 128Q nematodes with no effect in 19Q nematodes and no
change in transgene expression (Figure 1A). These results
suggested that lin-18 up-regulation is toxic to 128Q neurons and
that Ryk inhibition may provide protection from mutant polyQ
cytotoxicity.
Reducing Ryk Levels Decreases the Vulnerability of
Mutant htt Striatal Cells
Having observed that neuronal dysfunction was suppressed by
lin-18/Ryk LOF in 128Q nematodes, we tested if Ryk inhibition
could decrease the cell death caused by full-length mutant HTT.
To this end, we used striatal cells derived from the HdhQ111
knock-in mice [23]. Mutant htt (109Q/109Q) striatal cells are
abnormally susceptible to cell death as induced by serum
deprivation [23], a phenotype suitable for identifying modifiers
of cell vulnerability [30]. As indicated by qRT-PCR and Western
Figure 1. Analysis of Ryk in polyQ nematodes and striatal cells
derived from HdhQ111 mice. (A) Modulation of touch response of
polyQ nematodes by LOF of lin-18/RYK. Shown are the results in C.
elegans transgenics expressing expanded (128Q) or normal (19Q) exon-
1–like htt transgenes in touch receptor neurons. The 128Q-mediated
loss of touch response is ameliorated by LOF of lin-18/RYK. No effects
are detected in 19Q nematodes. Data are mean 6 SEM with more than
200 animals tested per genotype. *p,0.001 versus 128Q controls. LOF
of lin-18/RYK does not modify 128Q transgene expression levels as
tested by qRT-PCR (right panel, data are mean 6 SEM with n=5).
Significance was tested using one-way ANOVA, with correction for
multiple testing by Tukey’s Multiple Comparison Test. (B) Mutant htt
(109Q/109Q) striatal cells have increased Ryk levels. Data for qRT-PCR
are mean 6 SEM (n= 7). **p,0.01 versus normal htt (7Q/7Q) cells. Data
for Western blotting are mean 6 SD (n= 3). **p,0.01 versus normal htt
(7Q/7Q) cells. Significance was tested using paired t tests. (C) Reducing
Ryk levels decreased the mortality of 109Q/109Q striatal cells induced
by serum deprivation compared to scramble situation, with no effect
detected in 7Q/7Q cells. Western blotting was used to test expression
levels as 109Q/109Q cells do not display HTT aggregation. Mutant htt
levels were unchanged by knockdown of Ryk. Data are mean 6 SD
(n= 4). *p,0.01 versus scramble. The RNA sequences shown are
indicated in the Materials and Methods section. Significance was tested
using paired t tests.
doi:10.1371/journal.pbio.1001895.g001
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blotting, Ryk mRNA and protein levels are two times higher in
109/109Q cells compared to normal (7Q/7Q) cells (Figure 1B).
To test whether reducing Ryk levels may promote mutant htt
striatal cell survival, we subjected 109Q/109Q and 7Q/7Q cells
to Ryk siRNA treatment. Ryk siRNA treatment enhanced the
survival of 109Q/109Q cells with no effect on 7Q/7Q cells, an
effect unrelated to a change in HTT expression (Figure 1C). This
was consistent with neuroprotection by lin-18/Ryk LOF in 128Q
nematodes, further suggesting that Ryk has a pathological role in
HD neurons.
Neuroprotection by lin-18/Ryk LOF Requires daf-16/FoxO
Activity
We next sought to examine the mechanisms underlying
neuroprotection by Ryk inhibition. We first tested whether
neuroprotection by lin-18/Ryk LOF in expanded-polyQ nema-
todes (see Figure 1A) occurred in a cell-autonomous manner. The
expression of lin-18 cDNA in touch receptor neurons (4 ng/ml)
using the mec-3 promoter abolished neuroprotection by lin-18 LOF
in 128Q nematodes with no effect detected in 19Q nematodes as
observed in two independent arrays per polyQ genotype
(Figure 2A), indicating that neuroprotection by lin-18 LOF is cell
autonomous. Ryk participates in canonical Wnt signaling [26] and
there is a functional interaction between b-catenin, a downstream
effector of canonical Wnt, and FOXO in oxidative stress signaling
[9]. We thus tested whether lin-18 required bar-1/b-catenin and
daf-16/FoxO activity to modulate neuronal dysfunction in 128Q
nematodes. In 19Q nematodes, LOF of lin-18 (see Figure 1A), daf-
16 (see [1]), and bar-1 (see [10]) had no effect on touch response. In
128Q nematodes, bar-1 LOF exacerbated the loss of touch
response (Figure 2B), with no change in transgenic protein
expression (Figure 2C), suggesting that bar-1 normally protects
touch neurons from 128Q. The same applied to daf-16 LOF
(Figure 2B/C), as previously observed [7]. In 128Q;lin-18(e620)
animals, neuroprotection by lin-18 LOF was reduced by LOF of
bar-1 (Figure 2B) with no change in transgenic protein expression
(Figure 2C), suggesting that lin-18 activity requires bar-1. However,
the effect of bar-1 LOF in 128Q;lin-18(e620) nematodes was
partial, suggesting a role for other genes. In contrast, neuropro-
tection by lin-18 LOF was suppressed by daf-16 LOF (Figure 2B),
an effect unrelated to a change in transgenic protein expression
(Figure 2C), indicating that neuroprotection by lin-18 LOF fully
requires daf-16. Given that daf-16 is normally neuroprotective
(Figure 2B), this indicated that lin-18 may repress daf-16 activity in
128Q nematodes, which led us to investigate the mechanisms by
which Ryk may repress FOXO activity.
The Ryk ICD Binds to b-Catenin
Ryk signals through multiple mechanisms such as the canonical
Wnt pathway and the nuclear translocation of its cleaved ICD to
regulate neuronal differentiation [16]. This suggests that one
mechanism for Ryk to repress FOXO in mutant polyQ neurons
might be the deregulation of canonical Wnt, a neuroprotective
pathway [11]. However, LOF of pop-1/TCF does not appear to
modulate 128Q neurotoxicity in C. elegans nematodes (unpublished
data), suggesting that the outcome of the canonical Wnt pathway is
not critical to mutant polyQ neuron survival. We thus hypothe-
sized that another mechanism for Ryk to repress FOXO in mutant
polyQ neurons could involve a noncanonical mechanism, namely
the binding of the Ryk-ICD to FOXO or its partner b-catenin.
It was previously shown that b-catenin associates with Ryk [31].
Consistent with these findings, we also observed that b-catenin
binds to Ryk by using constructs that code for Ryk with a Myc tag
at the C-terminal end or an uncleavable Ryk mutant (Ryk:
EGFRRc, a chimeric construct in which the transmembrane
region was replaced with that of the EGF receptor) [16]. These
constructs were transfected into 293T cells (derived from human
kidney cells) and cell lysates subjected to immunoprecipitation
using an anti-Myc antibody followed by immunoblotting. In the
cells expressing Ryk or uncleavable Ryk, immunonoprecipitation
of Myc-tagged Ryk pulled down endogenous b-catenin (Figure 3A),
as expected.
To examine if Ryk-ICD binds to b-catenin, Flag-tagged Ryk-
ICD constructs were transfected into 293T cells. b-catenin was
detected in the anti-Flag immunoprecipitate, suggesting that Ryk-
ICD is sufficient to associate with b-catenin (Figure 3B). Similar
Figure 2. Neuroprotection by lin-18/Ryk LOF is a cell-autonomous process that requires daf-16/FoxO activity. (A) Expression of lin-18
cDNA in touch receptor neurons using the mec-3 promoter abolishes the neuroprotective activity of lin-18 LOF in 128Q nematodes with no effect
detected in 19Q nematodes as tested in two independent extrachromosomal arrays (A1, A2) per polyQ genotype. The expression of lin-18 cDNA was
confirmed by RT-PCR followed with enzymatic restriction for all of the arrays generated (unpublished data). Data are mean 6 SEM (more than 200
animals tested). *p,0.001 compared to 128Q transgenics; **p,0.001 compared to 128Q;lin-18 nematodes. (B) Neuron dysfunction is aggravated by
bar-1/b-catenin or daf-16/FoxO LOF in 128Q nematodes, and protection from 128Q toxicity by lin-18 LOF is reduced by LOF of bar-1 and suppressed
by LOF of daf-16. Data are mean 6 SEM (more than 200 animals tested). **p,0.001 compared to 128Q transgenics; ***p,0.001 compared to
128Q;lin-18 nematodes. (C) lin-18, bar-1 and daf-16 LOF alone or in combination do not change transgenic protein expression levels in 128Q
nematodes. Data are mean 6 SD (n=3). Significance was tested using one-way ANOVA, with correction for multiple testing by Tukey’s Multiple
Comparison Test.
doi:10.1371/journal.pbio.1001895.g002
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experiments aimed at testing for binding of Ryk-ICD to FOXO3a,
a neuroprotective FOXO protein [32], did not detect any
interaction (unpublished data). Together, these results suggested
that Ryk might signal onto FOXO through binding of its ICD
fragment to the FOXO co-factor b-catenin.
Ryk-ICD Represses FOXO3a Activity in Luciferase
Reporter Assays
We then sought to test whether an excess of Ryk may repress
FOXO transcriptional activity. We also tested whether an excess
of the c-secretase–cleaved ICD of Ryk may have a similar effect, as
the Ryk-ICD fragment associates with b-catenin (see Figure 3B), a
protein that promotes FOXO transcriptional activity [9]. We
examined the activity of FOXO3a, a protein that is neuroprotec-
tive in models of motor neuron disease [32], also protecting against
cell death associated with mutant HTT in striatal cells from
HdhQ111 knock-in mice (Figure 4A/B). From here, we further
examined the molecular relationships between FOXO3a, b-
catenin, and Ryk in mutant polyQ toxicity. To this end, constructs
encoding FOXO3a together with a Forkhead responsive element
(FHRE)-luciferase reporter and internal control reporter were
utilized to transfect mouse striatal cells that express normal HTT.
Reducing b-catenin levels reduced luciferase activity compared to
control cells (Figure 4C/D), which is consistent with the ability of
b-catenin to promote FOXO transcriptional activity in mouse cells
[9]. Overexpressing Ryk reduced luciferase activity to levels
comparable to those observed for b-catenin siRNA treatment
(Figure 4C), suggesting that Ryk up-regulation can repress
FOXO3a transcriptional activity. Western blotting indicated that
this effect might be attributable to full-length Ryk and to a Ryk C-
terminal fragment (Ryk CTF) of ,47 kDa (Figure 4D). However,
the CTF fragment is too large to be the c-secretase cleavage
product of Ryk (Ryk-ICD, ,40 kDa). The size of this fragment
suggests that Ryk CTF contains the ICD plus the transmembrane
domain and a portion of the extracellular domain, which is
consistent with the possibility that other proteases might cleave the
extracellular domain of Ryk near the transmembrane domain
[33]. The Ryk-ICD fragment was not visible, which might be
attributable to a very short half-life of this fragment similar to what
has been observed for the c-secretase–cleaved intracellular
fragment of transmembrane proteins such as the amyloid
precursor protein (APP) [34]. Interestingly, Ryk-ICD overexpres-
sion produced a similar reduction of luciferase activity compared
to Ryk overexpression (Figure 4C/D), indicating that Ryk-ICD is
sufficient to repress FOXO3a transcriptional activity. Further-
more, overexpressing a mutant form of Ryk that cannot undergo
c-secretase cleavage (Ryk: EGFRRc) showed no effect on
luciferase activity (Figure 4C). Mutant Ryk was detected as one
fragment corresponding to full-length Ryk and one fragment
corresponding to Ryk CTF (Figure 4D). In contrast to cells
transfected with wild-type Ryk, the full-length Ryk precursor
appeared to be more abundant in cells transfected with mutant
Ryk (Figure 4D). This suggests that blocking the c-site of Ryk may
also block Ryk CTF generation, an effect that was previously
shown for APP [35] and that further points to putative similarities
between Ryk and APP processing. Collectively, these results
suggested that the generation of the Ryk-ICD fragment is
important for the cytotoxic action of Ryk.
LIN-18 ICD Suppresses Neuroprotection by lin-18 LOF in
Expanded-PolyQ Nematodes
We next tested whether the Ryk ICD has a role in mutant
polyQ cytotoxicity as predicted by its ability to repress FOXO
transcriptional and neuroprotective activity. In 128Q nematodes,
lin-18/Ryk LOF is neuroprotective, and this effect is cell
autonomous, as LIN-18 overexpression in touch receptor neurons
suppresses the neuroprotective effect of lin-18 LOF (see Figure 2A).
Interestingly, overexpression (at a dose of 4 ng/ml) of the LIN-18
ICD was sufficient to suppress the protective effect of lin-18 LOF
on touch response in 128Q nematodes with no effect detected in
19Q nematodes as tested in two independent arrays per polyQ
genotype (Figure 5A). Although overexpressing LIN-18 ICD at
higher doses (40 ng/ml) showed a trend towards exacerbation of
128Q cytotoxicity but did not reach statistical significance relative
to control (Figure S5), overexpressing LIN-18 ICD at 40 ng/ml
produced cytotoxicity in 19Q nematodes (Figure S5), suggesting
Figure 3. Ryk ICD binds to b-catenin. (A) b-catenin binds to Ryk. Constructs of Myc-tagged Ryk or uncleavable Ryk (Ryk:EGFR Rc) were transfected
into 293T cells. Ryk proteins were immunoprecipitated with anti-Myc antibody, and beta-catenin associated with Ryk was determined by
immunoblotting. Ryk ICD can be detected in the cells expressing wild-type Ryk. (B) The ICD of Ryk binds to b-catenin. Cells expressing Flag-tagged
Ryk-ICD were used for anti-Flag immunoprecipitation. The ICD and associated b-catenin were determined by Western blot. NE, nuclear extract;
FUIGW-FLAG, vector FUIGW plus a Flag sequence.
doi:10.1371/journal.pbio.1001895.g003
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that LIN-18 ICD has dose-dependent effects in polyQ;lin-18
nematodes. The overexpression (4 ng/ml) of LIN-18 ICD was also
sufficient to suppress the protective effect of lin-18 LOF on axonal
swelling (Figure 5B), accompanying the loss of touch response in
128Q nematodes [15]. Given that overexpressing the Ryk-ICD
fragment is sufficient to reduce FOXO transcriptional activity
(Figure 4C/D), this further suggested that the Ryk-ICD fragment
mediates Ryk cytotoxicity.
Ryk-ICD Is Cytotoxic in Mouse Striatal Cells Expressing
Mutant htt
Next, we tested whether overexpressing the Ryk-ICD fragment
may be cytotoxic in striatal cells derived from HdhQ111 knock-in
mice [23] and whether this involves b-catenin activity. To this end,
striatal cells were transfected with either a construct coding for
Myc-tagged Ryk-ICD or a construct coding for V5-tagged b-
catenin, or both, and these cells were subjected to serum
deprivation. The overexpression of Ryk-ICD showed no effect
on normal htt cell survival (Figure 5C/D). These results are
consistent with the absence of toxicity for LIN-18 and LIN-18
ICD overexpression in normal-polyQ nematodes (see Figure 2A,
Figure 5A), supporting a model in which Ryk up-regulation
represses a mechanism (FOXO activity) that specifically promotes
mutant polyQ neuron survival. Although mutant htt cells have
high endogenous Ryk levels (see Figure 1B), overexpressing Ryk-
ICD potentiated cell mortality (Figure 5C/D). This effect was
moderate, however, suggesting that Ryk toxicity is close to a
maximum in these cells. Consistent with the pro-survival role of b-
catenin, overexpressing b-catenin reduced the cell death of mutant
htt cells with no effect detected in normal htt cells (Figure 5C/D).
The protective effect of b-catenin overexpression in mutant htt
cells was abolished by Ryk-ICD overexpression (Figure 5C/D),
suggesting that Ryk-ICD may antagonize b-catenin activity. There
was no significant difference between the mortality of mutant htt
cells transfected with Ryk-ICD alone and that of cells co-
transfected with Ryk-ICD and b-catenin (Figure 5C/D). None-
theless, cells co-transfected with Ryk-ICD and b-catenin showed
similar levels of mortality compared to cells transfected with the
empty vector (Figure 5C/D), suggesting that b-catenin overex-
pression may compensate for Ryk-ICD cytotoxicity to that extent.
As such, these results might just reflect the parallel activity of two
proteins with antagonistic properties in the regulation of cell
survival. However, given that Ryk-ICD binds to b-catenin (see
Figure 3), these results supported a model in which a functional
cross-talk between Ryk-ICD and b-catenin contributes to Ryk-
ICD cytotoxicity.
Reducing Presenilin 1 Levels Compensates for the
Cytotoxicity of Full-Length Ryk in Mutant htt Mouse
Striatal Cells
Our results in C. elegans neurons and mouse striatal cells suggest
a model in which the repression of FOXO3a activity by Ryk in
mutant polyQ cells is mediated by the Ryk-ICD fragment, a c-
secretase cleavage product. The c-secretase complex has been
previously implicated in HD through its role in HTT cleavage and
production of N-terminal fragments CpA and CpB [36]. Here, we
sought to investigate the protective role of the c-secretase complex
relative to the pathological activity of Ryk in mutant polyQ cells.
To this end, we tested whether decreasing the activity of the c-
secretase complex might promote the survival of mutant htt mouse
striatal cells and whether this effect might compensate for Ryk
toxicity in these cells. At this point in our study, we elected to
measure caspase 3/7 activity instead of counting picnotic nuclei in
order to perform faster and complementary measures of striatal
cell mortality. We observed that reducing the expression of
presenilins PS1 or PS2 enhanced the viability of mutant htt striatal
cells, with no effect detected in normal htt cells (Figure 6A/B).
Most importantly, reducing the levels of PS1 compensated for the
cytotoxic effect of overexpressing full-length Ryk but not that of
overexpressing Ryk-ICD in mutant htt cells (Figure 6C). The
compensatory effects of reducing PS1 levels on Ryk cytotoxicity
was accompanied by an apparent increase of full-length Ryk levels
as inferred from Western blot analysis (Figure 6D). A decrease of
the CTFs that may be generated by the sequential proteolysis of
Ryk such as Ryk-CTF and Ryk-ICD [33] was also apparent,
however to a lesser extent (Figure 6D). Given that Ryk-ICD may
result from PS1 cleavage, as previously investigated in PS1-
deficients cells [16], these results suggested that Ryk toxicity may
be triggered by the production of Ryk-ICD in mutant htt cells,
which led us to analyze endogenous Ryk-ICD levels in these cells.
Ryk-ICD Is Increased in the Nucleus of Mutant htt Striatal
Cells
The model supported by our data for Ryk to be toxic in HD
suggests that Ryk-ICD levels might be increased in mutant polyQ
cells. To explore this possibility, we used a newly obtained rabbit
polyclonal Ryk-ICD antibody (anti-RykICD) [33] to perform
immunocytostaining of mouse striatal cells followed by confocal
analysis. This antibody was raised against the Ryk-ICD fragment,
and it recognizes Ryk species that contain the ICD including full-
length Ryk and the Ryk-ICD fragment [33]. Depending on the
type of cells and level of expression in these cells, this antibody may
detect one or more of all possible Ryk species. The detection of
Figure 4. The Ryk ICD represses the transcriptional activity of FOXO3a, a protein that protects from mutant HTT. (A) Foxo3a siRNA
treatment enhances the mortality of mutant htt striatal cells subjected to serum deprivation, whereas FOXO3a overexpression (O/E) has the opposite
effect. Data are mean 6 SD (n=4). *p,0.001 compared to scramble; **p,0.001 compared to empty vector control. (B) Representative Western blots
showing decreased (si-Foxo3a) or increased (FOXO3a O/E) FOXO3a levels and no change in HTT protein levels. (C) FOXO transcriptional activity was
measured in normal htt mouse striatal cells. Cells were cultured in normal conditions and co-transfected with a construct encoding FOXO3a together
with the reporter FHRE-luciferase, which contains three canonical FOXO binding sites, and an internal Renilla luciferase reporter construct. Luciferase
and Renilla luciferase activities were measured and the ratio (luciferase/Renilla luciferase)10,000 calculated. Data are mean 6 SD of four independent
experiments performed in triplicate. Treatment with b-catenin siRNA, full-length Ryk cDNA, and Ryk-ICD cDNA reduces luciferase activity to similar
levels, whereas treatment with uncleavable Ryk showed no effect. *p,0.001 compared to FHRE-luc, **p,0.001 compared to scramble RNA and
***p,0.001 compared to FOXO3a O/E. Significance was tested using one-way ANOVA, with correction for multiple testing by Tukey’s Multiple
Comparison Test. (D) Representative Western blots showing increased levels of FOXO3a and decreased levels of b-catenin, and expression of Myc-
tagged Ryk, Myc-tagged Ryk-ICD, and Myc-tagged c-secretase–uncleavable Ryk (all proteins with a Myc tag at the C-terminal end). The Myc-tagged
Ryk and c-secretase–uncleavable Ryk proteins were detected as two fragments, one corresponding to the full-length Ryk precursor (Ryk) and one
corresponding to a Ryk CTF (Ryk CTF) resulting from proteolytic cleavage in the extracellular domain near the transmembrane domain. The full-length
Ryk precursor is less abundant for wild-type Ryk expression compared to mutant Ryk expression (see Results for the discussion of Ryk expression
profiles).
doi:10.1371/journal.pbio.1001895.g004
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Figure 5. The Ryk ICD is cytotoxic in C. elegans neurons and mouse striatal cells expressing expanded polyQs. (A) Expression of LIN-18
ICD cDNA (4 ng/ml) in touch receptor neurons using the mec-3 promoter is sufficient to abolish the neuroprotective activity of lin-18 LOF in 128Q
nematodes with no effect detected in 19Q nematodes as tested in two independent extrachromosomal arrays (128Q: A1 is ID1333, A2 is ID1334; 19Q:
A1 is ID1331, A2 is ID1332; see also Table S8) per polyQ genotype. The expression of LIN-18 ICD cDNA was confirmed by RT-PCR for all of the arrays
generated. Data are mean 6 SEM (more than 200 animals tested). **p,0.001 compared to 128Q animals, **p,0.001 compared to 128Q;lin-18
animals. ns, not significant. Significance was tested using one-way ANOVA, with correction for multiple testing by Tukey’s Multiple Comparison Test.
(B) Expression of LIN-18 ICD cDNA (4 ng/ml) in touch receptor neurons using the mec-3 promoter is also sufficient to abolish the protective activity of
lin-18 LOF on axonal swelling in the PLM neurons of 128Q nematodes as tested in two independent extrachromosomal arrays (Lin-18 ICD: A1 is
ID1333, A2 is ID1334; Lin-18: A1 is ID1325, A2 is ID1326). The expression of LIN-18 ICD cDNA was confirmed by RT-PCR for all of the arrays generated.
Expression of empty vector (4 ng/ml) showed no effect as tested in two independent extrachromosomal arrays (A1 is ID1339, A2 is ID1340). Data are
mean 6 SEM (more than 200 animals tested). *p,0.001 compared to 128Q animals, **p,0.001 compared to 128Q;lin-18 animals. ns, not significant.
Significance was tested using one-way ANOVA, with correction for multiple testing by Tukey’s Multiple Comparison Test. The lower panel shows a
representative image of axonal swelling in the anterior process of posterior touch receptor neurons of 128Q nematodes co-expressing HTT1-57::CFP
and YFP [7]. Swelling (white arrows, YFP signals are pseudocolored in green) and HTT::CFP aggregation (yellow arrows, CFP signals are pseudocolored
in red) are shown. Magnification is 1006and scale bar is 5 mM. (C) Overexpressing either V5-tagged b-catenin or Myc-tagged Ryk-ICD or both has no
effect on the mortality induced by serum deprivation in normal htt striatal cells. Overexpressing b-catenin reduces the mortality induced by serum
deprivation in mutant htt striatal cells, whereas overexpressing the Ryk-ICD aggravates cell mortality. Co-expressing Ryk-ICD and b-catenin resulted in
cell mortality levels that are similar to those induced by empty vector overexpression. Data are mean 6 SD (n= 4). *p,0.01 and **p,0.05 compared
to empty vector. ns, not significant. Significance was tested using paired t tests. (D) Representative Western blot showing increased V5-tagged b-
catenin and Myc-tagged Ryk-ICD levels after transfection of 7Q/7Q and 109Q/109Q striatal cells.
doi:10.1371/journal.pbio.1001895.g005
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Ryk species is also dependent on the methods used for expression
analysis (see Western blot in Figure S6) and likely to be dependent
on epitope accessibility. Immunocytostaining of mouse striatal cells
indicated that Ryk-ICD immunoreactivity was primarily localized
in the nucleus, with little signal detected in the cytoplasm and no
signal detected at the membrane (Figure 7A/B). Additionally, the
intensity of nuclear staining was decreased if Ryk expression is
reduced (Figure S7). These results suggested that full-length Ryk
might be rapidly processed to produce intracellular fragments that
localize to the nucleus. Interestingly, nuclear Ryk-ICD levels
appeared to be increased by about 25% in mutant htt cells
compared to normal htt cells, with no change detected in the
cytoplasm (Figure 7A/B). This effect was observed for normal and
mutant htt cells cultured on the same slides and for cell nuclei
having similar sizes between genotypes. We further investigated
the possibility that nuclear Ryk-ICD levels may be increased by
using an internal control for improved comparison of Ryk-ICD
levels between normal and mutant htt cell nuclei. We elected to
use Pol2 immunostaining as a second antigen, as we observed that
Pol2 levels are similar between normal and mutant htt cells.
Figure 6. Reducing presenilin 1 expression counteracts the cytotoxicity of full-length Ryk overexpression in mutant htt striatal
cells. Assays were performed using caspase 3/7 activity in cells subjected to serum deprivation. (A) PS1 and PS2 siRNA treatment enhances the
viability of mutant htt striatal cells. Data are mean 6 SD (n=3), *p,0.01 compared to scramble RNA. Significance was tested using one-way ANOVA,
with correction for multiple testing by Tukey’s Multiple Comparison Test. (B) Representative Western blots showing decreased levels of PS1/PS2. (C)
Knockdown of PS1 reduces the cytotoxic effects of overexpressing full-length Ryk in mutant htt striatal cells, with no effect detected on the cytotoxic
effects of overexpressing Ryk-ICD. Data are mean6 SD (n= 4), *p,0.05 and **p,0.01 compared to scramble RNA. Significance was tested using one-
way ANOVA, with correction for multiple testing by Tukey’s Multiple Comparison Test. EV, empty vector; ns, not significant. (D) Representative
Western blots showing decreased levels of PS1 and expression of Myc-tagged Ryk species and Myc-tagged Ryk-ICD. *Nonspecific signal.
doi:10.1371/journal.pbio.1001895.g006
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Nuclear Ryk-ICD levels were increased by about 40% in mutant
htt cells in these experiments (Figure 7C/D). Collectively, these
observations suggested that nuclear Ryk-ICD levels may be
significantly increased in mutant htt cells, corroborating the C.
elegans and striatal cell data on the toxic effects of Ryk-ICD
overexpression (see Figures 5 and 6) and further supporting a
model in which the ICD of Ryk triggers the detrimental effects of
Ryk increase in mutant polyQ cells.
Figure 7. The ICD of Ryk is increased in the nucleus of mutant htt striatal cells. (A) Representative confocal microscopy images showing the
pattern of Ryk-ICD immunoreactivity in normal htt (7Q/7Q) and mutant htt (109Q/109Q) striatal cells under normal culture conditions (no serum
starvation) as detected using the rabbit polyclonal antibody anti-RykICD. (B) Quantification of Ryk-ICD immunoreactivity in mouse striatal cells. 7Q/7Q
and 109Q/109Q cells were grown on the same slides. Comparisons were performed for cells with a nucleus size in the range of 150–250 pixels. Ryk-
ICD immunoreactivity was increased in the nucleus of 109Q/109Q cells compared to 7Q/7Q cells. Data are mean6 SEM for the ratio Intensity/Area as
detected in either nucleus or cytoplasm (n= 3 for a total of at least 100 cells analyzed), ***p,0.0001 compared to normal htt cells; n.s., not significant.
Significance was tested using one-way ANOVA, with correction for multiple testing by Tukey’s Multiple Comparison Test. Ryk siRNA treatments were
observed to reduce nuclear Ryk-ICD immunoreactivity in 109Q/109Q cells (see Figure S6). (C) Representative confocal microscopy images showing
the pattern of Ryk-ICD immunoreactivity in normal htt (7Q/7Q) and mutant htt (109Q/109Q) striatal cells under normal culture conditions (no serum
starvation) as detected using the rabbit polyclonal antibody anti-RykICD and mouse Pol2 antibody 7C2. (D) Quantification of Ryk-ICD and Pol2
immunoreactivity in mouse striatal cells. 7Q/7Q and 109Q/109Q cells were grown on the same slides. Comparisons were performed for cells with a
nucleus size in the range of 150–250 pixels. The ratio for Ryk-ICD/Pol2 immunoreactivity was increased in the nucleus of 109Q/109Q cells compared
to 7Q/7Q cells. Data are mean 6 SEM for the ratio Intensity Ryk-ICD/Intensity Pol2 as detected in the nucleus (n= 4 for a total of at least 100 cells
analyzed), **p,0.002 compared to normal htt cells. Significance was tested using Welch’s t test.
doi:10.1371/journal.pbio.1001895.g007
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Striatal Ryk Expression Profiles in 140CAG Knock-in Mice
and HD Patients
In 128Q nematodes, lin-18/Ryk is up-regulated at an early
stage of touch receptor neuron genesis (see Figure S4, Table S5)—
that is, before the onset of pathology (loss of touch response) as
detected in late larvae/young adults [7]. This led us to explore
whether Ryk might be increased before or at an early stage of
pathology in HD mice. Although there are a number of fragment
and full-length genetic mouse models of HD, each possessing
useful experimental outcomes that can be used to provide a greater
understanding of the human disease process, full-length knock-in
HD mice such as 140CAG mice [24] may provide the best
possible genetic comparability to human HD. Western blot
analysis of protein extracts from the striatum of 140CAG mice
using a N-terminal Ryk antibody showed that Ryk can be detected
as two bands, one band corresponding to full-length Ryk and a
weaker band of ,28 kDa (Figure S8A). The weaker band likely
corresponds to an extracellular fragment of Ryk that is generated
by proteolytic cleavage near the transmembrane domain,
illustrating again (see Figure 4D) the possibility that Ryk may be
cleaved by several proteases [33]. Densitometric analysis of Ryk
showed an increase of immunofluorescence activity in the
neostriatum of 140CAG HD mice at 8 mo of age (Figure S8B).
To explore the chronological features of Ryk increase in the
striatum of 140CAG mice, we performed immunohistochemical
analysis and observed a significant age-dependent increase of Ryk
levels at 2, 4, 6, and 8 mo of age (Figure S8C). Because running
wheel and sensorimotor deficits may begin at 4 mo in the
140CAG HD mice with climbing deficits detected at 1.5 mo [24],
this observation suggested that Ryk might be increased prior to the
onset or during the early phases of motor decline in these mice.
We next explored striatal Ryk expression in HD brains. Human
HD brain tissue specimens were age-matched and postmortem
interval-matched. Densitometric analysis of Ryk showed a
significant increase of immunofluorescence in grade 1/2 HD
patients (Figure S9A). In contrast to large cholinergic neurons and
medium-sized NADPH-diaphorase aspiny neurons, medium-sized
spiny GABAergic projection neurons of the HD striatum are
affected early and most severely [37]. To further explore Ryk
immunoreactivity within the striatum of HD patients, we
performed double immunofluorescence for Ryk in combination
with either calbindin or NOS immunoreactivities, labeling
degenerating and relatively unaffected striatal neurons, respec-
tively. Ryk co-localized with calbindin-positive striatal neurons,
with no cross-reactivity with spared NOS-positive neurons (Figure
S9B), suggesting that Ryk immunoreactivity might correlate with
the selective neuronal loss observed in HD. Additionally, we tested
whether Ryk immunoreactivity might correlate with HD severity.
Little positive Ryk immunoreactivity was present in the control
specimens, with marked expression of Ryk immunoreactivity in all
HD tissue samples in neurons, neuropil, and other cell types with
increased degrees of neuropathological severity (Figure S9C).
Densitometric analysis showed grade-dependent increases in Ryk
immunoreactivity (Figure S9C). Finally, we used combined Ryk
GFAP immunofluorescence to test whether Ryk might be
increased in cells other than neurons for the most severe HD
grade (grade 4), in which few medium spiny neurons are left in the
caudate nucleus. Compared with age-matched normal specimens,
Ryk immunofluorescence was increased within astroglia from
caudate nucleus grade 4 HD, but not on a one-to-one basis (Figure
S10). Although Ryk immunofluorescence signals were observed in
the GFAP-negative area, and although there were glial figures
without co-localized Ryk, Ryk immunoreactivity appeared to be
predominantly from astrocytes (Figure S10), a possibility also
suggested by the densitometric analysis of Ryk immunoreactivity
in mouse striata (Figure S8B).
Collectively, these results suggested that Ryk may have discrete
patterns of increased expression in striata and caudate nuclei, an
aspect that will the subject of future studies that include additional
Ryk antibodies and brain samples.
Discussion
Wnt signaling regulates several developmental processes,
including synaptic differentiation, as well as adult neurogenesis
[11]. The activation of canonical and noncanonical Wnt pathways
may be neuroprotective in neurodegenerative disease as indicated
by studies of Ab oligomer toxicity [11]. Studies of polyglutamine
expansion [7] and Ab toxicity [8] indicates that the same applies to
the activation of the FOXO pathway, a pathway that is central to
cell survival/longevity [38] as well as neuronal cell homeostasis
[39]. Here, we found that Ryk, a Wnt receptor important to axon
guidance [40,41], is increased in mutant polyQ neurons and
represses FOXO neuroprotective activity, highlighting a patho-
logical situation in which the Wnt and FOXO pathways interact
to promote neuron dysfunction and degeneration. The Ryk
protein is involved in canonical Wnt to regulate neurite outgrowth,
being required for TCF-driven transcription through binding to
Frizzled and Dishevelled [26]. This raised the possibility that Ryk
might repress FOXO activity via the alteration of the canonical
Wnt/Fzd–b-catenin pathway. However, Wnt ligands such as cwn-
1/WNT4, cwn-2/WNT5, and egl-20/WNT16 and the transcrip-
tion factor pop-1/TCF did not appear to modulate 128Q
neurotoxicity in C. elegans, suggesting that canonical Ryk signaling
may not contribute to the toxicity of Ryk in mutant polyQ
neurons. Besides its ability to signal through the planar cell polarity
pathway [19,20], the Ryk protein can also signal through another
noncanonical pathway, namely the nuclear translocation of its
ICD (Ryk-ICD), a c-secretase cleavage product that is required for
cortical neurogenesis [16]. Here, we provide a model in which the
repression of FOXO by Ryk in mutant polyQ neurons may
primarily occur through the nuclear translocation of the Ryk-ICD
fragment. Our data noticeably indicate that (i) the free Ryk-ICD
fragment may be sufficient to repress FOXO activity in mutant
polyQ cells, (ii) the lin-18/Ryk ICD fragment is sufficient to
suppress the protective effects of lin-18 knock-out on the function
of polyQ-expanded nematode neurons, and (iii) the free Ryk-ICD
fragment may bind to b-catenin, and there is a functional cross-
talk between Ryk-ICD and b-catenin in the modulation of Ryk-
ICD cytotoxicity. These data support the possibility that
abnormally high amounts of Ryk-ICD may prevent the activity
of b-catenin, a survival protein [9,14,42] that promotes FOXO
transcriptional activity [9] and protects against the early phases of
mutant polyQ cytotoxicity [10]. This model is further supported
by our data linking Ryk and c-secretase PS1 in the modulation of
mutant htt striatal cell viability, and by our data on the increase of
endogenous Ryk-ICD levels in the nucleus of these cells.
Collectively, these observations point to the Ryk-ICD fragment
as an important mediator of the detrimental effects of Ryk
increase. The c-secretase complex is involved in the role of Ryk in
cortical neurogenesis [16] and has been previously implicated in
HD through its effect on HTT proteolysis and production of N-
terminal HTT species [36]. Our data suggest that c-secretases may
also have a role in the regulation of cell stress response in HD by
mediating the detrimental effects of Ryk increase on FOXO3a
activity. Here, it is noticeable that aph-1, the C. elegans homologue
of APH-1B [43], may be up-regulated by expanded polyQs, as
suggested by our microarray data from touch receptor cells, which
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might further contribute to the toxicity of the Ryk-ICD pathway in
mutant polyQ cells. Future research will build on these
observations to further investigate the mechanisms that may
underlie the pathological role of the Ryk-ICD/FOXO3a pathway
in HD. Besides testing whether Ryk cytotoxicity might be
modulated by mammalian Wnt ligands or Ryk inhibitory
antibodies [33] and studying whether an excess of the Ryk-ICD
fragment might tether b-catenin away from FOXO, it will be
interesting to identify the FOXO3a transcriptional targets that
may be deregulated by Ryk in mutant polyQ neurons and
understand how this may impact brain longevity mechanisms as
the pathogenic process develops in HD. The type and activity of
FOXO target genes may greatly depend on the cellular context in
which FOXO operates [4,44], which may also be true in HD, as
suggested by the study of context dependence in FOXO
interaction networks across mouse and human datasets [25].
Interestingly, the transcriptomic signature of 128Q nematode
touch receptor cells contains 84 genes that were previously
identified as putative daf-16/FOXO targets in C. elegans, including
31 genes that are highly conserved in mice (Table S7), suggesting
that FOXO target genes may be altered by mutant polyQ
expression. The deregulation status of most of these 31 genes
appeared to be greatly context-dependent, as evaluated by using
entropy-based feature selection across 14 HD-associated condi-
tions including murine striatum and human (postmortem brains,
blood samples, induced pluripotent stem cells) datasets (Table S7)
[5], which emphasizes the importance of context (e.g., cell type,
time requirement) in future analyses of the physiological impact of
abnormal Ryk signaling on FOXO activity in HD.
Lin-18/Ryk is up-regulated in 128Q nematode touch cells
before the loss of touch response—that is, prior to pathology in C.
elegans. In the neostriatum of 140CAG mice, Ryk increase is first
detected during the early phases of pathology in these mice, which
further links increased expression of Ryk with the early phases of
HD pathology. The alteration of Ryk may also be associated with
the human disease, as suggested by the grade-dependent increase
of Ryk immunoreactivity in the human HD caudate nucleus.
However, although the increase of Ryk detected in the neostri-
atum of 140CAG mice is unlikely to result from abnormal Ryk
degradation or age-dependent accumulation of Ryk as it was
observed in young mice, Ryk immunoreactivity in postmortem
HD brains might be influenced by several factors such as alteration
of cyto-architectural structure and disease-unrelated factors.
Similarly to other membrane proteins, Ryk might be processed
by several proteases that cleave Ryk in the vicinity of its
transmembrane domain [33], which might generate Ryk C-
terminal and N-terminal fragments with distinct localization and
half-life in brain tissues. Selective Ryk antibodies such as inhibitory
anti-Ryk antibody RWD1 were recently described [33], and these
antibodies will be useful in additional studies of Ryk expression in
the HD mouse and human HD brain.
The Ryk protein is solely represented in several genomes, and
reducing its pathological levels is anticipated to ameliorate
neurological disease, which makes this receptor an attractive
candidate for therapeutic intervention. Ryk is acutely induced in
models of CNS injury and in concert with Wnt signaling proteins
inhibits axon regeneration [45,46], suggesting that Ryk inhibition
may promote axon regeneration upon injury. Our findings identify
the inhibition of Ryk-ICD signaling as a therapeutic strategy to
restore cell stress response and neuronal function in HD and
perhaps in other neurodegenerative diseases. The up-regulation of
Ryk prior to pathology in 128Q nematodes, the up-regulation of
Ryk at the mRNA and protein levels in mutant htt striatal cells
derived from HdhQ111 mice, and the converging evidence for
nuclear Ryk-ICD to mediate Ryk neurotoxicity by altering FOXO
activity suggest that the inhibition of the Ryk-ICD pathway may
have therapeutic potential in HD.
In summary, our study reveals that Ryk activity is altered in
mutant polyQ neurons, with Ryk up-regulation promoting
neuronal dysfunction via the early-stage repression of FOXO
neuroprotective activity. Regardless of a possible contribution
from other mechanisms, our findings support a model in which the
ICD of Ryk, a c-secretase cleavage product, may be important for
the neurotoxic action of Ryk increase by altering the protective
activity of the b-catenin/FOXO complex. These data highlight a
pathological process in which neurodevelopmental pathways may
be altered during the early stages of the pathogenic process in
neurodegenerative disease to repress cell stress response and
‘‘neuronal longevity’’ mechanisms such as those controlled by
FOXO and its co-factors. Importantly, our data reveal that
neurons may be unable to develop an efficient FOXO-mediated
survival response against the earliest stages of mutant HTT
toxicity. This suggests that the early-stage restoration of neuronal
resistance capacity through the stimulation of cell-stress response
networks and mechanisms that are under FOXO control might
efficiently delay the pathogenic process in HD, which may have
significant implications for the prioritization of disease-modifying
strategies and identification of disease modifiers.
Materials and Methods
Ethics Statement
All the animal experiments were performed in accordance with
the Guide for the Care and Use of Laboratory Animals and were
approved by the Institutional Animal Care and Use Committee at
the University of Pittsburgh. Work involving human brain tissue
samples was approved by the institutional review board and the
Committee for Oversight of Research Involving the Dead at the
University of Pittsburgh.
C. elegans Assays
Nematode strains were handled using standard methods [47].
The integrated polyQ strains used in this study were previously
described [15,48] and all assays were performed blindly. Some
nematode strains used in this work were provided by the
Caenorhabditis Genetics Center, which is funded by the National
Institutes of Health National Center for Research Resources. The
complete list of strains used in this study is shown in Table S8.
Constructs encoding LIN-18 were generated as follows. The lin-18
cDNA was obtained from wild-type animals by RT-PCR, using
lin-18_attB5 (59-GGGGACAACTTTGTATACAAAAGTTGA-
TGTTCATCAGCAAAGAGGA) and lin-18_attB2 (59-GGGG-
ACCACTTTGTACAAGAAAGCTGGGTATTAGATGTATT-
GACTGAGT) primers. These primers contain, respectively, attB5
and attB2 sequences for recombination in the pDONR221-P5-P2
vector, using the Gateway system (Invitrogen). In parallel, we
produced a clone, in pDONR221-P1-P5r, containing the
promoter of mec-3, mec-3p, using primers RV3 (59-GGGGAC-
AAGTTTGTACAAAAAAGCAGGCTCCTGCAGGTACCCG-
GAGTAGTTG) and RV4 (59-GGGGACAACTTTTGTATA-
CAAAGTTGTGGCGCGCCAATGCGCGAAATTGTG GCT-
ACTC). Both clones were used to assemble mec-3p and lin-18, using
Gateway technology, in the destination vector pDEST-AN [49],
which is suitable for C. elegans transgenesis. To produce the construct
coding for the LIN-18 ICD, we used the same strategy. Briefly, we
used as a reverse primer lin-18_attB2, and a forward primer located
after the sequence that encodes LIN-18 ICD, RV61 (59-GGGGA-
CAACTTTGTATACAAAAGTTGAAAATGTTCAAGCGCTC-
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TAAAAAAGAAGA). Constructs were verified for sequence integ-
rity and were then injected at 4–40 ng/ml in 19Q;lin-18(e620) and
128Q;lin-18(e620) nematodes, together with pPD118.33 (a plasmid
containing myo-2p::GFP) at 10 ng/ml as a marker to follow
transgenesis and pUC18 as a DNA carrier to a final total DNA
concentration of 100–150 ng/ml, using standard methods. We
isolated at least two independent strains from each construct based
on GFP expression in the pharynx to perform touch assays and
axonal swelling assays. Touch response assays were carried out as
described [7]. Touch tests involved scoring for the response to light
touch at the tail by using a fine hair. Touch test were performed by
scoring 10 touches at the tail of the animal for a minimum of 200
animals per genotype. Ordinarily, wild-type animals will respond by
backing away from the touch. The responses were recorded for every
animal such that, for example, 3 responses out of 10 at the tail is given
as 30% responsiveness, and the mean values for responsiveness were
retained for comparison of nematode groups. Touch tests were
performed by two groups of two experimenters, and maximum
baseline variation was 9%. Axonal swelling was scored as previously
described [7]. Briefly, 128Q nematodes were mounted on agar pads
and immobilized using levamisole 20 mM, prior to examination on a
406 objective of a Leica Axioplan microscope, equipped with
fluorescence. A total of more than 150 animals per strain were
examined for axonal swelling in PLM neurons. Animals containing
at least one swollen axon were scored as positive. For strains
expressing extrachromosomal arrays, only animals expressing the
transgenic marker (i.e., GFP expressed in the pharynx under the
control of myo-2p) were assayed. Extraction of protein from whole
worms and Western blotting was conducted using standard methods
[50] and the following primary antibodies: GFP antiserum (Abcam,
1:5,000) and actin antibody (Molecular Probes, 1:5,000). Secondary
antibodies used were as follows: goat–anti-rabbit IgG HRP-
conjugated (Abcam, 1:10,000) and goat–anti-mouse IgG HRP-
conjugated (Biorad, 1:10,000). Proteins were detected by using ECL+
(ECL for actin) and evaluated by densitometry. Unpaired t tests were
used for statistics.
Primary Cultures of Embryonic Nematode Cells
Embryonic cells were obtained as previously described [51].
Briefly, embryos were isolated from gravid adults following lysis in
a hypochlorite solution. Eggshells were removed by incubation in
0.5 ml chitinase/chymotrypsine (1 U/ml and 3,000 U/ml, re-
spectively, in egg buffer) for 20 min. Following resuspension in egg
buffer, the embryos were dissociated by 0.25% trypsin treatment
for 5 min and resuspended in L-15 supplemented with antibiotics
and 20% FBS (L15-CM). Cells were plated on TESPA (4%,
Sigma) coated glass plates at a density of ,300,000 cells/cm2 and
maintained in L15-CM media. Cells were incubated at 20uC
overnight. Wild-type (N2) cells were isolated and treated similarly.
Microarray Experiments and Data Analysis
The materials and methods used for FACS sorting, RNA
extraction, microarray analysis, microarray data analysis, and RT-
PCR are described in Text S1.
Striatal Cell Mortality Assays
We used striatal cells homozygous for normal (7Q/7Q) or
mutant (109Q/109Q) htt derived from HdhQ111 knock-in mice
[23] and handled them as previously described [30]. Low-passage
(P9–P11) cell lines were used in all experiments. We used jetPEI-
FluoR for transfection with cDNA, jetSI-ENDO for siRNA assays,
and JetPrime for co-transfection with siRNA and cDNA as
indicated by the manufacturer (PolyPlus Transfection). The
siRNAs (si-Ryk, si-Foxo3a) and scramble RNAs were obtained
from QIAGEN and Operon, respectively. Mixes of 3–4 different
siRNA sequences per gene (each sequence at 25 or 33 nM) were
systematically tested for modulation of cell survival and target gene
expression, followed by the evaluation of individual siRNA
sequences at optimal concentration (100 nM). Effects on cell
survival were considered to be reliable if two different siRNAs
showed similar effects on target expression and cell survival and if
the scramble RNAs (100 nM; unique sequence that does match
with any sequence in the mouse genome) did not show any effect.
The active siRNA sequences shown in the figures are as follows: si-
Ryk, 59-GCAAATTAGTAGAAGCCAA-39 (100 nM); si-Foxo3a,
59-GCTTCATGCGCGTTCAGAA-39 (100 nM); siPS1, 59-GG-
AGCATTCTAACGAGTGA-39 (100 nM); and siPS2, 59-CTAT-
CAAGTCTGTGCGTTT-39 (100 nM). The corresponding scram-
ble RNAs shown in the figures are as follows: Ryk, 59-GA-
CGAAAGACCTATAATGA-39 (100 nM); Foxo3a, 59-GAGCTG-
TACCGATGACCTT-39 (100 nM); PS1, 59-ACGTAGTCA-
ATTCGGAGAG-39 (100 nM); and PS2, 59-GGTATTCCG-
TATTCGTCTA-39 (100 nM). For transfection with cDNA con-
structs, we used 1 mg pcDNA3.1-FOXO3a-HA (a gift from
Lisa Ellerby), pcDNA3.1/nV5-DEST-b-catenin (Addgene), or
pcDNA3.1-Myc-Ryk ICD. The Ryk-ICD fragment (amino acids
239 to 595) was amplified from mouse cell RNAs by RT-PCR using
the Ryk-ICD att-B1 59-GGGGACCACTTTGTACAAGAA-
AGCTGGGTATCAGACTGAGGCTCCCAGGGCAG-39 and
Ryk-ICD att-B2 59-GGGGACAAGTTTGTACAAAAAAGCA-
GGCTGCCGCCACCATGGAACAAAAACTTATTTCTGAAGAA-
GATCTGAAAAGGATTGAACTGGATGACG-39 primers. The
reverse primer contained a sequence (italicized) coding for a Myc
tag. PCR products were subcloned into the pDONR221 vector and
then into the final destination vector pcDNA3.1 using Gateway
technology and verified for sequence integrity.
Cell mortality assays were performed as described previously by
counting picnotic nuclei [52] or measuring caspase 3/7 activity
[53]. Briefly, low passage number (P9–P12) 7Q/7Q and 109Q/
109Q cells were subjected to a 24-h serum deprivation 48 h after
cell transfection. Cells were then fixed and subjected to DAPI
staining, and cell mortality was scored by counting picnotic versus
normal nuclei in DAPI- and jetPEI-FluoR–, or JetSI-ENDO–
positive cells. Alternatively, caspase assays were used and
transfected cells were plated on collagen-coated 96-well plates
for 48 h. After 24-h serum starvation, the activation of caspase 3/7
was measured in cells using the Apo 3/7 HTS High Throughput
Screen Assay kit (Cell Technology). The activity of caspase 3/7
was measured using a Tecan infinite F500 microplate reader, with
excitation and emission wavelengths of 485 and 535 nm,
respectively. Caspase assays were performed using six replicates
per point and data expressed as dRFU/min/mg of protein.
For qRT-PCR analysis, we used the forward 59-TGAGAGCT-
GACACACCCAA and reverse 59-CACTTCGCAAGTCGT-
TCTTC primers for amplification of Ryk mRNAs and forward
59-TTTGCCGCGAGCCG and reverse 59-TAACCTGGTT-
CATCATCGCTAATC primers for amplification of HPRT
mRNAs as a control. For Western blotting, proteins were
extracted as previously described [30], separated by SDS-PAGE,
and analyzed by Western blotting using the following primary
antibodies: mouse anti-HTT (4C8, Chemicon,1:5,000), rabbit
anti-RYK (Abgent, 1:100), mouse anti-FOXO3a (Cell Signaling,
1:1,000), rabbit anti-PS1 and rabbit anti-PS2 (Cell Signaling,
1:1,000), rabbit anti-Myc tag (Cell Signaling, 1:1,000), mouse anti-
V5 tag (InVitrogen, 1:2,000), and mouse anti-actin (MP Biomed-
icals, 1:5,000). Secondary antibodies used were as follows: goat–
anti-mouse IgG HRP-conjugated (Biorad, 1:10,000) and goat–
anti-rabbit IgG HRP-conjugated (Biorad, 1:10,000). Proteins were
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detected by using ECL+ (ECL for actin) and evaluated by
densitometry. Statistical analyses were performed using unpaired t
tests.
Immunoprecipitation Assays
To test for interaction between Ryk and b-catenin, transfection
of 293T cells with wild-type Myc-tagged Ryk, Flag-tagged RYK
ICD, or an uncleavable Ryk mutant (Ryk, EGFRRc) [16] was
performed using a calcium phosphate precipitation method [54].
Cells were lysed in a lysis buffer containing 25 mM Tris-HCl,
pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 10 mM
sodium pyrophosphate, 10 mM b-glycerophosphate, 1 mM sodi-
um orthovanadate, 10% glycerol, and protease inhibitors (Roche).
For immunoprecipitation, cell lysates were incubated with a
specific antibody for 2 h at 4uC and then with Protein A/G
agarose beads (Pierce) overnight. Immunoprecipitates were eluted
using SDS sample buffer and separated using 8% or 10% SDS-
PAGE. After blocking, the blots were incubated with a primary
antibody and then with a peroxidase-conjugated secondary
antibody. The bound secondary antibody was then detected using
enhanced chemiluminescence (ECL) reagent (Santa Cruz Bio-
technology). To test for an interaction between Ryk ICD and
FOXO3a, mouse striatal cells were transfected with Foxo3a-HA
and Myc-tagged Ryk-ICD using Jet PEI (PolyPlus Transfection) as
described by the manufacturer. Cells were lysed in PBS 0.1%
tween-20 supplemented with PMSF and protease inhibitors
(Roche). For immunoprecipitation, cell lysates were incubated
with a specific antibody for 2 h at 4uC and then with fastflow
Protein A agarose beads (Sigma) overnight at 4uC. Immunopre-
cipitates were eluted using SDS sample buffer and separated using
4%–12% SDS-PAGE (InVitrogen). The Ryk-ICD fragment
(amino acids 239 to 595) construct used in these experiments
was the same as above (see striatal cell vulnerability assays).
Luciferase Reporter Assays
Normal htt mouse striatal cells derived from HdhQ111 mice
and used at low passage numbers (P9–P12) were seeded in 96-well
plates, at a density of 25,000 cells/well, and were co-transfected
using Amaxa technology with 0.5 mg of the plasmid(s) pcDNA3.1-
Foxo3a-HA (a gift from Lisa Ellerby) together with pcDNA3.1-
Myc-Ryk (see below), pcDNA3.1-Myc-Ryk ICD (see above),
pcDNA3.1-Myc-uncleavable-Ryk (see above), 100 nM of b-
catenin siRNAs (QIAGEN) or scramble RNAs (Operon), 0.5 mg
of the luciferase reporter (FHRE-luc, Addgene) [55], which
contains three canonical FOXO binding sites, and 50 ng of the
Renilla luciferase construct (Promega). The pcDNA3.1-Myc-Ryk
construct was generated as follows: the Myc-Ryk coding sequence
was amplified from pCMV6-Myc-Ryk (Origene) by using the
primers forward 59-GGGGACAAGTTTGTACAAAAAAG-
CAGGCTGCCGCCACCATGCGCGCGGGCCGGGGC and
reverse 59-GGGGACCACTTTGTACAAGAAAGCTGGGT-
ATCAGACGTAGGCTCCCAGGGCAG and subcloned into
pcDNA3.1, and the resulting plasmid was verified for sequence
integrity. The pmaxGFP construct (Amaxa) was used as a control
for cotransfection. Transfection efficiency was greater than 80%.
One day after transfection, cells were lysed in 20 ml of lysis buffer
and the luciferase and Renilla luciferase activities assayed using
Stop & Glo reagents (Promega) according to the manufacturer’s
protocol. For the b-catenin siRNA experiments, effects were
considered to be reliable if two different siRNAs showed similar
effects on b-catenin expression and luciferase activity and if a
scramble RNA did not show any effect. The active b-catenin
siRNA and the scramble RNA that are shown in the figures are
59-GATAGAAATGGTCCGATTA-39 and 59-GTGTGAATG-
CATGAAACTA-39, respectively.
Confocal Analysis of Ryk ICD Signals
Endogenous Ryk-ICD levels were analyzed in 7Q/7Q and
109/109Q mouse striatal cells [23] by using the rabbit Ryk-ICD
antibody anti-RykICD [33]. Low-passage (P9–P11) cell lines were
grown in normal conditions (no serum starvation) and treated with
Ryk siRNAs or scramble RNAs as described above (see striatal cell
mortality assays) using Lab-Tek eight-chamber glass slides (BD
Biosciences). For comparison of Ryk-ICD levels between 7Q/7Q
and 109/109Q cells, cells were grown on the same slides. Cells
were fixed and permeabilized using the Cytofix/Cytoperm Kit
(BD Biosciences) following the manufacturer’s protocol. Cells were
then incubated with anti-RykICD (1:100) followed by incubation
with the anti-rabbit secondary antibody Alexa Fluor 488
(Invitrogen, 1:500) and subjected to diamidino-2-phenylindole
(DAPI) staining. Alternatively, cells were co-incubated with anti-
RykICD (1:100) and the Pol2 antibody 7C2 (1:500) followed by co-
incubation with the anti-rabbit secondary antibody Alexa Fluor
555 (Invitrogen, 1:500) and the anti-mouse secondary antibody
Alexa Fluor 488 (1:500), and cells were then subjected to DAPI
staining. Fluorescent signals were quantified using a confocal
microscope (Leica TCS SP5) and images analyzed using ImageJ.
For each of the focal planes, anti-RykICD signals were quantified
from the nucleus (DAPI staining). The comparison of 7Q/7Q and
109/109Q cells was based on cell nuclei that have a size of 150–
250 pixels in each of the cell lines. To assess cytoplasmic
expression, nuclear anti-RykICD signals were blackened, and the
remaining signals were quantified. Cytoplasmic analysis was
performed only if nuclear anti-RykICD signals were detected in
the same confocal plane and cell.
Brain Tissue Specimens
Mouse. Male full-length knock-in mice heterozygous for the
140CAG repeat mutation were obtained from an established
colony at the Bedford VA Medical Center and were backcrossed
with B6CBA females from Jackson Laboratory (Bar Harbor, ME).
The offspring were genotyped using a PCR assay on tail DNA.
Disease expression is present in these mice by 8 mo of age [56]
Groups (n=10) of 1-, 2-, 4-, or 8-mo-old mutant and littermate
wild-type control mice were deeply anesthetized and transcardially
perfused with 2% buffered paraformaldehyde (100 ml), with care
to avoid the introduction of any perfusion artifact. Brains were
removed, cryoprotected, and serially sectioned (50 mm). Serial cut
mouse tissue sections were subsequently immunostained for RYK
immunofluorescence.
Human. Postmortem striatal tissue specimens from 15 adult-
onset HD patients (two Grade 1, four Grade 2, four Grade 3, and
five Grade 4 cases; mean age of death, 65.3 y; range, 54–72 y) and
six age-matched patients without any known neurological sequella
(mean age, 67.2 y; range, 60–78 y) were dissected fresh and placed
in cold (4uC) 2% paraformaldehyde–lysine–periodate solution for
24–36 h. Brain tissue specimens were received from the Bedford
VA Medical Center Brain Tissue Archive. The postmortem
intervals did not exceed 15 h (mean time, 10.7 h; range, 4–15 h)
and were similar for controls and HD patients. CAG repeat length
analysis was performed on the HD specimens (mean number of
CAG repeats, 44.6). The range of CAG repeats in the adult-onset
HD patients was 41–49. Each HD patient had been clinically
diagnosed based on known family history and phenotypic
symptoms of HD. The diagnosis of HD was confirmed by
neuropathological examination and graded by severity [57]
Striatal tissue blocks were rinsed in 0.1 M sodium phosphate
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buffer and placed in cold cryoprotectant in increasing concentra-
tions of 10% and 20% glycerol, 2% DMSO solution for 24–36 h.
Frozen serial sections of the striatal tissue blocks from the anterior
commissure to the rostral extent of the globus pallidus were cut at
50-mm intervals in the coronal plane and placed within a six-well
collection container. The cut sections were stored in 0.1 M sodium
phosphate buffer and 0.08% sodium azide at 4uC for subsequent
Nissl and immunohistochemical techniques. The cut sections were
stored in 0.1 M sodium phosphate buffer with 0.08% sodium
azide at 4uC for subsequent immunocytochemistry, immunofluo-
rescence, and combined immunofluorescence methods for tyro-
sine-protein kinase RYK precursor (RYK), calbindin, and nitric
oxide synthase (NOS) antibodies. Tissue sections were examined
using a Nikon Eclipse E800 microscope with a Spot RT digital
camera.
Immunocytochemistry and Fluorescent
Immunocytochemistry
The methods used for immunocytochemistry and fluorescent
immunocytochemistry analyses of mouse tissue samples and
human tissue specimens are described in Text S2.
Western Blot Image Processing
Western blot membranes were exposed to films. After exposure,
films were scanned at high resolution (1,200 dpi) using a regular
scanner (Epson), and scans (tiff files) were opened into Photoshop
and Western blot images processed using PowerPoint and
Photoshop (Microsoft) for constructing final figures. Alternatively,
Western blot membranes were scanned at high resolution
(692 dpi) using a luminescent image analyzer (FUJIFILM LAS-
4000), and scans (tiff files) were opened into ImageJ and Western
blot images processed as previously mentioned for constructing
final figures.
Statistical Analysis
Statistical analysis of variance (ANOVA), t tests, and Welch’s t
tests were performed using Prism. One-way ANOVA was followed
by correction for multiple testing by Tukey’s Multiple Comparison
Test. The statistical analysis of microarray data and statistical
methods used for biological annotations are described in Text S2.
Supporting Information
Figure S1 Gene Ontology classification of genes specifically
deregulated by expanded polyQ expression in nematode neurons
(Pmec-3 targets). Genes were classified based on their functional
annotations in the GO categories ‘‘Biological Process,’’ ‘‘Molec-
ular Function,’’ and ‘‘Cellular Component.’’ The number of genes
is indicated.
(TIF)
Figure S2 Stable Fourier analysis modules containing genes up-
regulated in 128Q nematode neurons (Pmec-3 targets). The genes
up-regulated (FDR ,0.01) in nematode neurons are indicated by
green nodes. Node borders in purple and blue indicate down- and
up-regulation (p,0.01) of the human best ortholog in the caudate
nucleus of HD patients, respectively, as previously reported [29].
Square nodes indicate druggable genes [28]. The enrichment in
GO annotations was generated using Gostat and enrichments
considered significant for p,0.001. Four modules described the
extracellular matrix (Nos. 1–3, No. 5), three modules membrane
proteins (Nos. 4–6), two modules the cytoskeleton (Nos. 7–8), nine
modules the mitochondria (Nos. 9–13, 22–23, 26, 37), one module
the golgi apparatus (No. 14), and five modules the nucleus (Nos.
15–20), with other modules corresponding to carbohydrate
metabolism (Nos. 21–24), lipid metabolism (Nos. 25–27), chaper-
ones (Nos. 37–39), and general metabolism (Nos. 28–36). Of note,
module 40 contained components involved in signaling pathways
(Wnt and TGF-b), axonal guidance, and cell cycle.
(PDF)
Figure S3 Stable Fourier analysis modules containing genes
down-regulated in 128Q nematode neurons (Pmec-3 targets). The
genes down-regulated (FDR,0.01) in nematode neurons are
indicated by red nodes. Node borders in purple and blue indicate
down- and up-regulation (p,0.01) of the human best ortholog in
the caudate nucleus of HD patients, respectively, as previously
reported ([29]; see [3]). Square nodes indicate druggable genes
[28]. The enrichment in GO annotations was generated using
Gostat and enrichments considered significant for p,0.001. The
modules obtained described extracellular components (Nos. 1–3),
membrane (Nos. 4–10), transport (No. 11), nucleus (Nos. 13–15),
calcium sensors (No. 21), metabolism (Nos. 16–19), and signal
transducers such as neuropeptides and the Ras and hedgehog
pathways (Nos. 23–28).
(PDF)
Figure S4 Fourier analysis module containing the Wnt, TGF-b,
and nonsense-mediated mRNA decay pathways (up-regulated
module 40). Green nodes indicate up-regulated nematode genes
with FDR,0.01. Node borders in purple and blue indicate down-
and up-regulation, respectively, of human homologs in HD
caudate nucleus [29] with p,0.01. Square shapes indicate
druggable genes [28].
(TIF)
Figure S5 Effects of overexpressing LIN-18 ICD at 40 ng/ml in
polyQ;lin-18 nematodes. Overexpressing LIN-18 ICD cDNA at
40 ng/ml in touch receptor neurons using the mec-3 promoter
abolishes the neuroprotective activity of lin-18 LOF in 128Q
nematodes. This effect showed a trend toward exacerbation of
128Q cytotoxicity but did not reach statistical significance relative
to 128Q nematodes. Overexpressing LIN-18 ICD at 40 ng/ml
produced cytotoxicity in 19Q nematodes. Two independent lin-18
ICD extrachromosomal arrays (A1, A2) were tested per polyQ
genotype. The expression of LIN-18 ICD cDNA was confirmed by
RT-PCR for all of the arrays generated. EV, empty vector
overexpression. Data are means 6 SEM (more than 200 animals
tested). *p,0.001 compared to 19Q animals. ns, not significant.
Significance was tested using one-way ANOVA, with correction
for multiple testing by Tukey’s Multiple Comparison Test.
(TIF)
Figure S6 Effects of Ryk siRNA treatment and Ryk-ICD
overexpression on the detection of Ryk species by antibody anti-
RykICD in protein extracts from 109/109Q mouse striatal cells.
Representative Western blot showing that Ryk siRNA treatment
reduces the detection of full-length Ryk (Ryk FL), an effect
accompanied by decreased Ryk mRNA levels as tested by qRT-
PCR (left panel). Although the antibody anti-RykICD does not
detect endogeneous levels of Ryk-ICD in these experiments, it
detects Ryk-ICD when this Ryk fragment is overexpressed (Ryk-
ICD O/E), with no signal detected for empty vector (right panel).
(TIF)
Figure S7 Ryk siRNA treatment decreases nuclear Ryk-ICD
immunoreactivity in 109/109Q mouse striatal cells. (A) Repre-
sentative confocal images showing the pattern of Ryk-ICD
immunoreactivity in 109Q/109Q striatal cells upon scramble
RNA or Ryk siRNA treatment as detected using the rabbit
polyclonal antibody anti-RykICD. The Ryk-ICD signals were
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primarily detected in the nucleus, with weak signals detected in the
cytoplasm. (B) Quantification of anti-RykICD nuclear signals in
109Q/109Q striatal cells. Nuclear Ryk-ICD immunoreactivity
was decreased by about 25% by Ryk siRNA treatments. Data are
mean 6 SEM for the ratio Intensity/Area as detected in nuclei
(n=3 for a total of at least 90 cells analyzed), ***p,0.0001
compared to scramble RNA. Reduction of Ryk mRNA levels
(mean reduction, 54%) was tested by qRT-PCR.
(TIF)
Figure S8 Ryk is increased in the striatum of 140CAG HD
mice. (A) Western blot analysis of Ryk expression in striatal protein
lysates from 4-wk-old 140CAG homozygous mutant mice (n=3).
Using the N-terminal Ryk antibody Ab7577a without or with
preincubation with blocking peptide BP7577a, two specific bands
were detected, including one band corresponding to the full-length
protein and a weaker band of ,28 kDa likely corresponding to a
Ryk extracellular domain fragment (see comments in the Results
section). (B) Densitometric analysis showed an increase of Ryk
immunofluorescence from the striata of 8-mo-old 140CAG HD
mice (lower panel) compared with controls (upper panel) (n=10
per genotype), *p,0.04. Scale bar, 50 mm. Significance was tested
using one-way ANOVA. (C) Chronological immunohistochemical
analysis of Ryk expression in the striatum of 140CAG mice. Left
panels show example images for 140CAG mice at 1, 2, 4, 6, and
8 mo of age (a–e). Scale bar, 100 mm. Right panels show example
images for wild-type mice at 1, 2, 4, 6, and 8 mo (a*–e*). 140CAG
mice show a significant age-dependent increase of Ryk levels at 2,
4, 6, and 8 mo of age. Data are means 6 SD with n=10 in each
group. *p,0.001 compared to control. Significance was tested
using one-way ANOVA, with correction for multiple testing by
Tukey’s Multiple Comparison Test.
(TIF)
Figure S9 Ryk is increased in human HD caudate nucleus. Ryk
immunofluorescence was assessed using the same Ryk antibody as
in Figure S7. (A) Compared with age-matched controls (upper
panel), Ryk immunofluorescence was increased in human caudate
nucleus of grade 1/2 patients (lower panel). Densitometric analysis
(right panel) showed increased Ryk protein levels in HD caudate
nucleus (right) compared with controls (left) (n=6 per group), *p,
0.02. Scale bar, 50 mm. Significance was tested using one-way
ANOVA. (B) Selective Ryk expression in brain striata. Combined
immunofluorescence showed that Ryk co-localized (white arrows)
with calbindin (degenerating neurons) but not with NOS
immunoreactivity (spared neurons) in caudate neurons in brains
from HD patients. Some level of co-localization was detected in
control brain striata. (C) Densitometric analysis showed a disease
grade-dependent increase of RYK immunoreactivity in human
HD caudate nucleus. Level of Ryk expression in control (n=5),
Grade 1 HD (n=4), Grade 2 HD (n=5), Grade 3 HD (n=5), and
Grade 4 HD (n=4) samples. *p,0.05 compared to control; **p,
0.02 compared to Grade 1 HD; ***p,0.01 compared to Grade 2
HD; ****p,0.01 compared to Grade 3 HD. Also shown are
images of Ryk immunostaining. (a) Immunoexpression of Ryk was
low in the brain tissues of age-matched controls. (b–e) Increased
Ryk immunoreactivity correlated with the degree of neuropath-
ological severity (b, Control; c, Grade 1; d, Grade 2; e, Grade 3; f,
Grade 4). Scale bar, 100 mm. Significance was tested using one-
way ANOVA, with correction for multiple testing by Tukey’s
Multiple Comparison Test.
(TIF)
Figure S10 Partial co-localization of Ryk and GFAP immuno-
fluorescence in Grade 4 HD caudate nucleus. Combined Ryk
GFAP immunofluorescence shows co-localization with Ryk and
GFAP in both Grade 4 HD (HD G4) striatum and, to a much
smaller degree, in normal age-matched (Control) specimens.
Compared with age-matched control specimens (a–d), Ryk
immunofluorescence was increased within astroglia from human
caudate nucleus Grade 4 HD patients (e–f), but not on a one-to-
one basis. Several Ryk immunofluorescence signals were observed
in the GFAP-negative area (white arrows), and there are multiple
glial figures without co-localized Ryk. Ryk immunofluorescence
was assessed using the same Ryk antibody as in Figure S8. Scale
bar, 20 mm.
(TIF)
Table S1 Genes deregulated in 19Q nematode cells versus
control (GFP alone) cells. Forty-one worm genes were found to be
deregulated. Most of them were down-regulated (34/41) and
about a half of them encoded extracellular and catalytic proteins
or were associated to membranes. Gene Ontology (GO)
enrichment tests indicated that Pepsin A activity (GO:0004194)
was enriched (p,0.01). Among these 41 genes, six genes conserved
in humans. Also shown are the best homologous genes in humans
with their expression levels in the HD brain (caudate and cortex)
versus control brains [29]. Human genes deregulated in HD
caudate nucleus and cortex are labeled in orange and green,
respectively (p,0.01).
(PDF)
Table S2 Genes deregulated in 128Q nematode cells versus
19Q nematode cells. We found 2,070 worm genes to be
deregulated. Only 18 of the 2,070 genes were also deregulated
in 19Q nematode cells versus GFP cells, including pqn-48, a
lysosomal thiol reductase, and four nematode-specific genes
encoding membrane proteins: srg-64, nspb-2, nspb-5, and str-180.
Also found were nematode genes with no human homologs as
inferred from Inparanoid [58], including a lectine (clec-219),
innexin (inx-4), and xylosyltransferase enzyme (sqv-6). Among the
2,070 dysregulated genes, 516 genes are conserved in humans.
Also shown are the best homologous genes in humans with their
expression levels in HD brains (caudate and cortex) versus control
brains [29]. Human genes deregulated in HD caudate nucleus and
cortex are labeled in orange and green, respectively (p,0.01).
(PDF)
Table S3 GSEA of deregulated genes in nematode cells. For
each enrichment category shown, gene sets are shown by
increasing normalized enrichment score (NES) values. No
enrichment was detected for 19Q cells. Enrichments were
considered to be significant for FDR q-Val ,0.25 as previously
described [59]. This analysis was performed using gene sets from
wormbook*, KEGG annotations$, and Gene Ontology annota-
tions with# or without¥ Inferred from Electronic Annotation.
(DOCX)
Table S4 Pathways and processes enriched in genes specifically
deregulated by 128Q expression as shown by GSEA. n is the count
of genes found in the gene set enriched in deregulation versus the
total Gene Set. *Underlined are the genes deregulated in 128Q
cells (FDR,0.01) or human HD caudate nucleus as previously
reported [29] (p,0.01) or both. **%H is the percent of core genes
with human homolog(s) as indicated by Inparanoid clusters. Gene
sets are from Wormbook***, KEGG annotations$, and Gene
Ontology annotations with¥ or without# Inferred from Electronic
Annotation.
(DOCX)
Table S5 RT-PCR analysis for hits of interest as emphasized by
microarray data analysis.
(DOCX)
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Table S6 Pathways/processes highlighted by Fourier analysis
and GSEA.
(DOCX)
Table S7 Putative daf-16/FOXO transcriptional targets that are
also found in the transcriptomic signature of expanded-polyQ
nematode touch cells. Data on putative daf-16/FOXO targets are
from the studies of Murphy et al. [60], MacElwee et al. [61], and
Oh et al. [62]. *Microarray data. **Chromatin immunoprecipi-
tation data. ***Gene expression entropy was assessed using
entropy-based feature selection as previously described [5] across
14 HD-associated conditions including the striatum of N-terminal
htt transgenic mice R6/2 (at 6 wk and 12 wk) and D9-N171-98Q
(a.k.a. DE5; at 14 mo) [63,64], full-length htt transgenic mice
YAC128 (at 12 mo and 24 mo), knock-in mice CHL2 (at 22 mo)
and HdH(Q92/Q92) (at 18 mo), caudate nucleus and BA4/BA9
cortex from post-mortem HD brains [29], blood samples from
presymptomatic and symptomatic HD carriers [65], and HD-
induced pluripotent stem (iPS) cells that were differentiated into
neural stem cell (NSC) lines and that expressed 60 or 180 CAG
repeats [66]. Most putative daf-16 targets that are highly conserved
in the mouse have moderate to high entropy values, suggesting
that their behavior is significantly dependent on the HD-associated
context (cell type, time requirement) in which they operate. NA,
not applicable.
(DOCX)
Table S8 Names and genotypes of the C. elegans strains used in
this study.
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Text S1 Supplementary materials and methods.
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Text S2 Supplementary results.
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